The expression of CD44 glycoprotein adhesion molecules in basal cell carcinomas is related to growth pattern and invasiveness

British Journal of Dermatology

Volumn 140, Issue 1, 1999, Pages 17-25

  Dingemans, K P ^a   Ramkema, M D ^a   Koopman, G ^a,b   Van Der Wal, A C ^a   Das, P K ^a   Pals, S T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Basal cell carcinoma; CD44; Growth pattern; Invasiveness

Indexed keywords

CD44V ANTIGEN; CELL ADHESION MOLECULE; GLYCOPROTEIN; HERMES ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN RETRIEVAL; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER INVASION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBEDDING; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; PRIORITY JOURNAL; STROMA; TISSUE SECTION; TUMOR CELL;

ACTINS; ANTIGENS, CD44; CARCINOMA, BASAL CELL; CELL DIVISION; COLORING AGENTS; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; PARAFFIN EMBEDDING; PILOT PROJECTS; SKIN NEOPLASMS;

EID: 0033048082     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02602.x     Document Type: Article

References (37)

1. Lesley J, Hyman R, Kinkade PW. CD44 and its interactions with the extracellular matrix. Adv Immunol 1993; 54: 271-335.
2. Günthert U, Hofmann M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
3. Koopman G, Heider KH, Horst E et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177: 897-904.
4. Wielenga VJM, Heider KH, Offerhaus GJA et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 51: 4754-6.
5. Kauffmann M, Heider KH, Sinn HP et al. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 14: 615-9.
6. MacKie RM. Epidermal skin tumours. In: Textbook of Dermatology, 5th Edn, Vol. 2 (Champion RH, Burton JL, Ebling FJG, eds). Oxford: Blackwell Scientific Publications, 1992; 1488-95.
7. Wade TR, Ackerman AB. The many faces of basal-cell carcinoma. J Dermatol Surg Oncol 1978; 4: 21-8.
8. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. J Am Acad Dermatol 1990; 23: 1118-26.
9. Baum HP, Schmid T, Shock G, Reichrath J. Expression of CD44 isoforms in basal cell carcinomas. Br J Dermatol 1996; 114: 465-8.
10. Guttinger M, Sutti F, Barnier C et al. Expression of CD44 standard and variant forms in skin tumors. Loss of CD44 correlates with aggressive potential. Eur J Dermatol 1995; 5: 398-406.
11. Halle LP, Dhavalkumar DP, Clark RE, Haynes BF. Distribution of CD44 variant isoforms in human skin: Differential expression in components of benign and malignant epithelia. J Cutan Pathol 1995; 22: 536-45.
12. Prieto VG, Reed JA, McNutt NS et al. Differential expression of CD44 in malignant cutaneous epithelial neoplasms. Am J Dermatopathol 1995; 17: 447-51.
13. Seiter S, Tilgen W, Herrmann K et al. Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Arch 1996; 428: 141-9.
14. Seelentag WKF, Günthert U, Saremaslani P et al. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. In J Cancer 1996; 69: 218-24.
15. Yasaka N, Furue M, Tamaki K. CD44 expression in normal human skin and skin tumors. J Dermatol 1995; 22: 88-94.
16. Heenan PJ, Eider DE, Sobin LH. Basal cell carcinoma. In: Histogical Typing of Skin Tumours. New York: Springer-Verlag, 1996; 48-51.
17. Kirihara Y, Haratake J, Horie A. Clinicopathological and immunohistochemical study of basal cell carcinoma with reference to the features of basement membrane. J Dermatol 1992; 19: 161-9.
18. Miller SJ. Biology of basal cell carcinoma (part I). J Am Acad Dermatol 1991; 24: 1-13.
19. Murphy GF, Elder DE. Non-melanocytic tumors of the skin. In: Atlas of Tumor Pathology, 3rd series, Fascicle 1. Washington: Armed Forces of Pathology. 1991.
20. Undén AB, Sandstedt B, Bruce K et al. Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma but not in dermatofibrosarcoma. J Invest Dermatol 1996; 107: 147-55.
21. Dietrich A, Tanezos E, Vanscheidt W et al. Detection of CD44 splice variants in formalin-fixed, paraffin-embedded specimens of human skin cancer. J Cutan Pathol 1997; 24: 37-42.
22. Picker LJ, Nakache M, Butcher EC. Monclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 1989; 109: 927-37.
23. Tammi R, Ripellino JA, Margolis RU, Tammi M. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J Invest Dermatol 1988; 90: 412-14.
24. Haggerty IG, Bretton RH, Milstone LM. Identification and characterization of a cell surface proteoglycan on keratinocytes. J Invest Dermatol 1992; 99: 174-80.
25. Heider KH, Hofmann M, Horst E et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227-33.
26. Sahni M, Grön-Virta K, Sointu P et al. Regulated expression of exon v6 containing isoforms of CD44 in man: Downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993; 122: 411-42.
27. Weiss JM, Sleeman J, Renkl AC et al. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol 1991; 137: 1137-47.
28. Tsukamoto H, Hayashibe K, Mischima Y, Ichihashi M. The altered expression of alpha-smooth muscle actin in basal cell epithelioma and its surrounding stroma: With special reference to proliferating cell nuclear antigen expression and adenoid differentiation. Br J Dermatol 1994; 130: 189-94.
29. Simon JO, Heider KH, Dietrich A et al. Expression of CD44 isoforms in human skin cancer. Eur J Cancer 1996; 32A: 1394-400.
30. Günthert U. CD44: A multitude of isoforms with diverse functions. Curr Topics Microbiol Immunol 1993; 184: 47-63.
31. Tanaka Y, Adams DH, Hubscher S et al. T-cell adhesion induced by proteoglycan-immobilized cytokine MTP-1β. Nature 1993; 361: 79-82.
32. Bennett KL, Modrell B, Greenfield B et al. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 1995; 131: 1623-33.
33. Gabbert H. Mechanisms of tumor invasion: Evidence from in vivo studies. Cancer Met Rev 1985; 4: 293-309.
34. Dvorak HF. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-9.
35. Martin M, Pujuguet P, Martin F. Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Path Res Pract 1996; 192: 712-17.
36. Dingemans KP, Zeeman-Boeschoten IM, Keep RF, Das PK. Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. Int J Cancer 1993; 54: 1010-16.
37. Darby I, Skalli O, Gabbiani G. α-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990; 63: 21-9.